The 2023-2028 Outlook for Anti-Fog Lidding Films in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-fog lidding films in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antifibrinolytic Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antifibrinolytic drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Fatigue Cosmetics in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-fatigue cosmetics in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antiepileptic Therapeutics for Fibromyalgia in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antiepileptic therapeutics for fibromyalgia in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Epileptic Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-epileptic drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antiemetic chemotherapy drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antidepressants for major depressive disorders in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. gr...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antidiarrheal Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antidiarrheal drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antidepressants for anxiety disorders in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antidepressants in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antidepressants in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to make...
11/28/2022 | Japan Outlook 2023
